Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy

References

• SeufferleinTBachetJBVan CutsemERougierPGroup EGWPancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201223Suppl 7vii33vii4022997452
   PubMed Web of Science ®Google Scholar
• SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
   PubMed Web of Science ®Google Scholar
• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• ZengHZhengRGuoYCancer survival in China, 2003–2005: a population-based studyInt J Cancer201513681921193025242378
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
   PubMed Web of Science ®Google Scholar
• KamisawaTWoodLDItoiTTakaoriKPancreatic cancerLancet201638810039738526830752
   PubMed Web of Science ®Google Scholar
• HidalgoMPancreatic cancerN Engl J Med2010362171605161720427809
   PubMed Web of Science ®Google Scholar
• VincentAHermanJSchulickRHrubanRHGogginsMPancreatic cancerLancet2011378979160762021620466
   PubMed Web of Science ®Google Scholar
• CameronJLRiallTSColemanJBelcherKAOne thousand consecutive pancreaticoduodenectomiesAnn Surg20062441101516794383
   PubMed Web of Science ®Google Scholar
• GarceaGDennisonARPattendenCJNealCPSuttonCDBerryDPSurvival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literatureJOP2008929913218326920
   PubMedGoogle Scholar
• AnsariDRosendahlAElebroJAnderssonRSystematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancerBr J Surg20119881041105521644238
   PubMed Web of Science ®Google Scholar
• AndersSHuberWDifferential expression analysis for sequence count dataGenome Biol20101110R10620979621
   PubMed Web of Science ®Google Scholar
• LangfelderPHorvathSWGCNA: an R package for weighted correlation network analysisBMC Bioinformatics2008955919114008
   PubMed Web of Science ®Google Scholar
• ZhangBHorvathSA general framework for weighted gene co-expression network analysisStat Appl Genet Mol Biol20054 Article17
   PubMed Web of Science ®Google Scholar
• ZhouMZhaoHWangZIdentification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myelomaJ Exp Clin Cancer Res20153410226362431
   PubMed Web of Science ®Google Scholar
• ZhouXHuangZXuLA panel of 13-miRNA signature as a potential biomarker for predicting survival in pancreatic cancerOncotarget2016743696166962427626307
   PubMedGoogle Scholar
• HeagertyPJZhengYSurvival model predictive accuracy and ROC curvesBiometrics20056119210515737082
   PubMed Web of Science ®Google Scholar
• Huang daWShermanBTLempickiRASystematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNat Protoc200941445719131956
   PubMed Web of Science ®Google Scholar
• Huang daWShermanBTLempickiRABioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene listsNucleic Acids Res200937111319033363
   PubMed Web of Science ®Google Scholar
• ShannonPMarkielAOzierOCytoscape: a software environment for integrated models of biomolecular interaction networksGenome Res200313112498250414597658
   PubMed Web of Science ®Google Scholar
• MarechalRDemetterPNagyNHigh expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinomaBr J Cancer200910091444145119352387
   PubMedGoogle Scholar
• MarchesiFMontiPLeoneBEIncreased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4Cancer Res200464228420842715548713
   PubMed Web of Science ®Google Scholar
• LiaoWCWangHPHuangHYCXCR4 expression predicts early liver recurrence and poor survival after resection of pancreatic adenocarcinomaClin Transl Gastroenterol20123e2223238349
   PubMedGoogle Scholar
• HuangJYaoWYZhuQXAF1 as a prognostic biomarker and therapeutic target in pancreatic cancerCancer Sci2010101255956719922503
   PubMedGoogle Scholar
• CarboneAVizioBNovarinoAIL-18 paradox in pancreatic carcinoma: elevated serum levels of free IL-18 are correlated with poor survivalJ Immunother200932992093119816189
   PubMedGoogle Scholar
• SinnMSinnBVStrieflerJKSPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 studyAnn Oncol20142551025103224562449
   PubMed Web of Science ®Google Scholar
• HanWCaoFChenMBPrognostic value of SPARC in patients with pancreatic cancer: a systematic review and meta-analysisPLoS One2016111e014580326731428
   PubMedGoogle Scholar
• InfanteJRMatsubayashiHSatoNPeritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinomaJ Clin Oncol200725331932517235047
   PubMed Web of Science ®Google Scholar
• OikonomopoulosGMSyrigosKNSaifMWPrognostic factors in pancreatic cancerJOP201314432232423846918
   PubMedGoogle Scholar
• MaurielloCPolistenaAGambardellaCPancreatic stump closure after pancreatoduodenectomy in elderly patients: a retrospective clinical studyAging Clin Exp Res201729Suppl 13540
   PubMed Web of Science ®Google Scholar
• ConzoGGambardellaCTartagliaEPancreatic fistula following pancreatoduodenectomy. Evaluation of different surgical approaches in the management of pancreatic stump. Literature reviewInt J Sur201521Suppl 1S4S9
   PubMedGoogle Scholar
• BaileyPChangDKNonesKGenomic analyses identify molecular subtypes of pancreatic cancerNature20165317592475226909576
   PubMed Web of Science ®Google Scholar
• WangJQianJHuYArhGAP30 promotes p53 acetylation and function in colorectal cancerNat Commun20145473525156493
   PubMed Web of Science ®Google Scholar
• AtanackovicDHildebrandtYTemplinJRole of interleukin 16 in multiple myelomaJ Natl Cancer Inst2012104131005102022745469
   PubMedGoogle Scholar
• ComperatERoupretMDrouinSJTissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomyProstate201070151622162720687232
   PubMed Web of Science ®Google Scholar
• WoodsNTMonteiroANThompsonZJInterleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patientsMol Carcinog201554Suppl 1E172E18425597281
   PubMedGoogle Scholar
• HughesLRuthKRebbeckTRGiriVNGenetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American menProstate Cancer Prostatic Dis201316430831424061634
   PubMed Web of Science ®Google Scholar
• ScielzoCBertilaccioMTSimonettiGHS1 has a central role in the trafficking and homing of leukemic B cellsBlood2010116183537354620530793
   PubMed Web of Science ®Google Scholar
• ButrymAMajewskiMDzietczeniaJKuliczkowskiKMazurGHigh expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patientsLeuk Res201236787688022333038
   PubMedGoogle Scholar
• FrezzatoFGattazzoCMartiniVHS1, a Lyn kinase substrate, is abnormally expressed in B-chronic lymphocytic leukemia and correlates with response to fludarabine-based regimenPLoS One201276e39902
   Google Scholar
• ScielzoCGhiaPContiAHS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognosesJ Clin Invest200511561644165015931393
   PubMedGoogle Scholar
• ZhangJXiangYDingLUsing gene co-expression network analysis to predict biomarkers for chronic lymphocytic leukemiaBMC201011Suppl 9S5
   Google Scholar
• AraiEChikuSMoriTSingle-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomasCarcinogenesis20123381487149322610075
   PubMedGoogle Scholar
• PrincipeMBorgoniSCascioneMAlpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasisJ Hematol Oncol20171011628086938
   PubMedGoogle Scholar
• PerlAKDahlUWilgenbusPCremerHSembHChristoforiGReduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic beta tumor cellsNat Med19995328629110086383
   PubMedGoogle Scholar
• TsutsumiSMorohashiSKudoYL1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinomaJ Surg Oncol2011103766967321360711
   PubMed Web of Science ®Google Scholar
• LiHWangXFangYIntegrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinomaOncotarget2017
   Google Scholar
• BosJLLinking Rap to cell adhesionCurr Opin Cell Biol200517212312815780587
   PubMed Web of Science ®Google Scholar
• HuangMAnandSMurphyEAEGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activationOncogene201231222783279321963850
   PubMedGoogle Scholar
• KennedyALAdamsPDMortonJPRas, PI3K/Akt and senescence: paradoxes provide clues for pancreatic cancer therapySmall GTPases20112526426722292129
   PubMedGoogle Scholar
• HubbardPAMoodyCLMuraliRAllosteric modulation of Ras and the PI3K/AKT/mTOR pathway: emerging therapeutic opportunitiesFront Physiol2014547825566081
   PubMed Web of Science ®Google Scholar
• GiuliettiMOcchipintiGPrincipatoGPivaFIdentification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysisCell Oncol2017402181192
   PubMed Web of Science ®Google Scholar
• WangCJXuRHYuanQYBioinformatics method to analyze the mechanism of pancreatic cancer disorderJ Comput Biol201320644445223614574
   PubMed Web of Science ®Google Scholar
• CarstensJLCorrea de SampaioPYangDSpatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancerNat Commun201781509528447602
   PubMed Web of Science ®Google Scholar
• LiuLZhaoGWuWLow intratumoral regulatory T cells and high peritumoral CD8(+) T cells relate to long-term survival in patients with pancreatic ductal adenocarcinoma after pancreatectomyCancer Immunol Immunother2016651738226646849
   PubMedGoogle Scholar
• LiuHLGuanCJWuYJHuMGZhaoZMLiuRClinical significance of preoperative CD8+ central memory T cells for operable pancreatic asdenocarcinomaDig Surg201532643343826402444
   PubMedGoogle Scholar
• NiccolaiECappelloPTaddeiAPeripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinomaInt J Oncol201649139340127210467
   PubMedGoogle Scholar
• HiraokaNOnozatoKKosugeTHirohashiSPrevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesionsClin Cancer Res200612185423543417000676
   PubMed Web of Science ®Google Scholar
• FukunagaAMiyamotoMChoYCD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinomaPancreas2004281e26e3114707745
   PubMed Web of Science ®Google Scholar
• FerroneCRKattanMWTomlinsonJSThayerSPBrennanMFWarshawALValidation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survivalJ Clin Oncol200523307529753516234519
   PubMedGoogle Scholar
• BrennanMFKattanMWKlimstraDConlonKPrognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreasAnn Surg2004240229329815273554
   PubMed Web of Science ®Google Scholar
• de CastroSMBiereSSLagardeSMBuschORvan GulikTMGoumaDJValidation of a nomogram for predicting survival after resection for adenocarcinoma of the pancreasBr J Surg200996441742319283741
   PubMedGoogle Scholar